Vitamin E supplementation in people with cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 3, 2017, Pages

  Okebukola, Peter O ^a   Kansra, Sonal ^b   Barrett, Joanne ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO; VITAMIN;

ALPHA TOCOPHEROL DEFICIENCY; BODY HEIGHT; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INCIDENCE; NUTRITIONAL STATUS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADOLESCENT; BLOOD; CHEMISTRY; CHILD; DIETARY SUPPLEMENT; INFANT; META ANALYSIS; PRESCHOOL CHILD; VITAMIN E DEFICIENCY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN E; VITAMIN E DEFICIENCY; VITAMINS;

EID: 85014580290     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009422.pub3     Document Type: Review

References (53)

1. Harries JT, Muller DPR. Absorption of water miscible and fat soluble preparations of vitamin E in cystic fibrosis. 5th International Cystic Fibrosis Conference; 1969 Sept. 22-26; Cambridge, England. 1969:298-307. [CFGD Register: GN49]3271540
2. Keljo DJ, Giroir B, Jialal I. Circulating tumor necrosis factor alpha and interleukin-6 levels in cystic fibrosis, effect of vitamin E therapy [abstract]. Pediatric Pulmonology 2000;30 Suppl 20:326. [CFGD Register: GN87]3271542
3. Levin S. Muscular performance and vitamin E in cystic fibrosis [letter]. Archives of Disease in Childhood 1974;49(3):247. [CFGD Register: GN73a; MEDLINE: 74154485]3271545
4. Levin S, Gordon MH, Nitowsky HM, Goldman C, di Sant'Agnese P, Gordon HH. Studies of tocopherol deficiency in infants and children: VI. Evaluation of muscle strength and effect of tocopherol administration in children with cystic fibrosis. Pediatrics 1961;27:578-88. [CFGD Register: GN73b; DOI: 10.1136/adc.49.3.247-a; MEDLINE: 74154485]3271544
5. Wong LTK, Halstead C, Davidson AGF, Fang PM. Comparison of the efficacy of water-miscible and fat soluble vitamin E in the therapy of vitamin E deficiency in cystic fibrosis patients [abstract]. Pediatric Pulmonology 1988;5 Suppl 2:144. [CFGD Register: GN52]3271547
6. Jacquemin E, Hermeziu B, Kibleur Y, Friteau I, Mathieu D, Le Coz F, et al. Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. Journal of Clinical Pharmacy and Therapeutics 2009;34(5):515-22. [CFGD Register: GN216; MEDLINE: 96204950]3271549
7. NCT00889434 . Efficacy and safety study of EGCG/Tocotrienol in 18 patients with splicing-mutation-mediated cystic fibrosis (CF). http://clinicaltrials.gov/show/NCT00889434 (accessed 10 March 2012). [Clinicaltrials.gov: NCT00889434]3271551
8. Munck A, Ginies JL, Huet F, Wizla N, Gerardin M, Darviot E, et al. A new water-soluble oral vitamin E formulation in cystic fibrosis (CF) children [abstract]. Journal of Cystic Fibrosis 2010;9 Suppl 1:S91, Abstract no: 352. [CFGD Register: GN219; MEDLINE: 96204950]3271553
9. Nasr SZ, O'Leary MH, Hillermeier C. Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis. Journal of Pediatrics 1993;122(5 Pt 1):810-2. [CFGD Register: GN42]3271555
10. Papas K, Kalbfleisch J, Mohon R. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Digestive Diseases and Sciences 2007;52(2):347-52. [CFGD Register: GN114; MEDLINE: 96204950]3271557
11. Sagel SD, Sontag MK, Anthony MM, Emmett P, Papas KA. Safety and efficacy of an antioxidant-rich multivitamin supplement in cystic fibrosis. Journal of Cystic Fibrosis 2011;10(1):31-6. [Clincaltrials.gov: NCT01018303]3271559
12. Thomas PS, Bellamy M, Geddes D. Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid [letter]. Lancet 1995;346(8984):1230-1. [CFGD Register: GN77; MEDLINE: 96054866]3271561
13. Winklhofer-Roob BM, Shmerling DH, Schimek MG. Response of vitamin E deficient patients with cystic fibrosis (CF) to oral RRR-alpha-tocopherol or all-rac-alpha-tocopheryl acetate [abstract]. Clinical Nutrition 1992;11 Suppl:67. [CFGD Register: GN48b]3271563
14. Winklhofer Roob BM, van't Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. American Journal of Clinical Nutrition 1996;63(5):722-8. [CFGD Register: GN48a; MEDLINE: 96204950]3271565
15. Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. American Journal of Clinical Nutrition 2003;77(1):150-9. [CFGD Register: GN98]3271567
16. Aaron SD, Ramotar K, Ferris W, Vandemheen K, Saginur R, Tullis E, et al. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa. American Journal of Respiratory and Critical Care Medicine 2004;169:811-5.
17. Aparicio JM, Belanger-Quintana A, Suarez L. Ataxia with isolated vitamin E deficiency: case report and review of the literature. Journal of Pediatric Gastroenterology and Nutrition 2001;33(2):206-10.
18. Bell SC, Shepherd RW. Optimising nutrition in cystic fibrosis. Journal of Cystic Fibrosis 2002;1(2):47-50. [DOI: 10.1016/S1569-1993(02)00031-0]
19. Biesalski HK. Vitamin E requirements in parenteral nutrition. Gastroenterology 2009;137(5):S92-S104. [DOI: 10.1053/j.gastro.2009.07.073]
20. Bines JE, Truby HD, Armstrong DS, Carzino R, Grimwood R. Vitamin A and E deficiency and lung disease in infants with cystic fibrosis. Journal of Paediatrics and Child Health 2005;41:663-8.
21. Brigelius-Flohé R. Vitamin E: The Shrew Waiting to be Tamed. Free Radical Biology & Medicine 2009;46:543-54.
22. Ciofu O, Lykkesfeldt J. Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD007020.pub3]
23. Cynamon HA, Milov DE, Valenstein E, Wagner M. Effects of vitamin E deficiency on neurologic function in patients with cystic fibrosis. Pediatrics 1988;113:637-9.
24. Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Practice & Research. Clinical Gastroenterology 2006;20(3):531-46.
25. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
26. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. Journal of Pediatrics 2008;153(2):S4-S14.
27. Gee L, Abbott J, Conway S, Etherington C, Webb A. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000;55(11):946-54.
28. Goss CH, Rosenfeld M. Update on cystic fibrosis epidemiology. Current Opinion in Pulmonary Medicine 2004;10(6):510-4.
29. Hakim F, Kerem E, Rivlin J, Bentur L, Stankiewicz H, Bdolach-Abram T, et al. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 2007;45(3):347-53.
30. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
31. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from cochrane-handbook.org.
32. Higgins JPT, Deeks JJ, Altman DG on behalf of the Cochrane Statistical Methods Group, editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from cochrane-handbook.org.
33. Deeks JJ, Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group, editor(s) . Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from cochrane-handbook.org.
34. Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. Journal of Cystic Fibrosis 2005;4:7-26.
35. Koscik RL, Lai HJ, Laxova A, Zaremba KM, Kosorok MR, Douglas JA, et al. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. Journal of Pediatrics 2005;147(3 Suppl):S51-S56.
36. Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, et al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2008;178(1):42-9.
37. Linnane BM, Hall GL, Nolan G, Brennan S, Stick SM, Sly PD, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. American Journal of Respiratory and Critical Care Medicine 2008;178(12):1238-44.
38. Mayo Clinic. Vitamin E (oral route). www.mayoclinic.com/health/drug-information/DR601967/FLUSHCACHE=0&UPDATEAPP=false (accessed 01 March 2011).
39. Peters SA, Kelly FJ. Vitamin E supplementation in cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 1996;22:341-5.
40. Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009;135(6):1610-8.
41. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
42. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkampd G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. Journal of Cystic Fibrosis 2002;1(2):51-75. [PUBMED: 15463811]
43. Suskind DL. Nutritional Deficiencies During Normal Growth. Pediatric Clinics of North America 2009;56(5):1035-53.
44. Swann IL, Kendra JR. Anaemia, vitamin E deficiency and failure to thrive in an infant. Clinical and Laboratory Haematology 1998;20(1):61-3.
45. Taylor C, Connolly S. Gastrointestinal disease and nutrition. In: Horsley A, Cunningham S, Innes JA editor(s). Cystic Fibrosis. Oxford: Oxford University Press, 2010:81-93.
46. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Annals of Clinical Biochemistry 1986;23(Pt 5):514-20.
47. Ueda N, Suzuki Y, Rino Y, Takahashi T, Imada T, Takanashi Y, et al. Correlation between neurological dysfunction with vitamin E deficiency and gastrectomy. Journal of the Neurological Sciences 2009;287:216-20. [DOI: 10.1016/j.jns.2009.07.020]
48. UK Cystic Fibrosis Trust Nutrition Working Group. Nutritional Management of Cystic Fibrosis. UK Cystic Fibrosis Trust, April 2002. [ISBN 0-9540536-5-6]
49. Welsh M, Ramsey B, Accurso F, Cutting G. Cystic Fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D editor(s). The Metabolic and Molecular Basis of Inherited Disease. 8th Edition. New York: McGraw-Hill, 2001:5121-88.
50. Wilfond BS, Farrell PM, Laxova A, Mischler E. Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening. Clinica Pediatrica 1994;33(1):2-7.
51. Winbauer AN, Pingree SS, Nuttall KL. Evaluating serum alpha-tocopherol (vitamin E) in terms of a lipid ratio. Annals Clinical and Laboratory Science 1999;29(3):185-91.
52. Okebukola PO, Kansra S, McCabe H. Vitamin E supplementation in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD009422]
53. Okebukola PO, Kansra S, Barrett J. Vitamin E supplementation in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD009422.pub2]